期刊文献+

儿童严重脓毒症和脓毒性休克继发肾上腺皮质功能不全的研究进展

原文传递
导出
摘要 脓毒症(sepsis)是继发于感染的全身炎症反应综合征(systemic inflammatory response syndrome,SIRS)。在脓毒症的基础上,出现器官功能障碍、低灌注或低血压称作严重脓毒症(severe sepsis),脓毒症休克(septic shock)定义为脓毒症并液体复苏难以纠正的低血压。美国2001年流行病调查显示,儿童脓毒症发病率为0.056%,婴幼儿发病率最高可达0.56%,病死率为10.6%,严重威胁儿童的健康。
作者 武洁 钱素云
出处 《中华儿科杂志》 CAS CSCD 北大核心 2010年第1期29-32,共4页 Chinese Journal of Pediatrics
  • 相关文献

参考文献29

  • 1Watson RS,Caecfllo JA,Linde-Zwirble WT,et al.The epidemiology of severe sepsis in children in the Unite States.Am J Respir Crit Care Med,2003,167:697-701.
  • 2Hatherill M,Tibby SM,Hilliard T,et al.Adrenal insufficiency in septic shock Arch Dis Child,1999,80(1):51-55.
  • 3Menno K.Clarson C.Adrenal function in pediatric critical illness.Pediatr Crit Care Med,2002,3:112-116.
  • 4张育才,章赛吉,滕国良,田国力,徐梁,曹瑞芬,张宇鸣.促肾上腺皮质激素刺激对脓毒症及脓毒性休克患儿肾上腺功能评估的意义[J].中华儿科杂志,2008,46(5):328-332. 被引量:8
  • 5Beishuizen A,Thijs LG.Endotoxin and the hypothalamo-pituitary-adrenal(HPA)axis.J Endotoxin Bes,2003,9(1):23-24.
  • 6Pralong FP,Reduit R,Waeber G,et al.Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland.Endocrinology,1998,139:4264-4268.
  • 7Yudt MR,Jewell CM,Bienstock RJ,et al.Molecular origins for the dominant negative function of human glucocorticoid recep tor beta.Mel Cell Biol,2003,23:4319-4330.
  • 8Ali M,Allen HR,Vedockis WV,et al.Depletion of rat liver glucocerticoid receptor hormone-binding and its mBNA in sepsis.Life Sci,1991,48:603-611.
  • 9Inlsen E,Matthews JG,Takahashi A,et al.p38 Mitogen-activated protein kinase-induced g]ucocorticoid receptor phosphorylation reduces it s activity:role in steroid-insensitive asthma.J Allergy Clin Immunol,2002,109:649-657.
  • 10Kam JC,Szefler SJ,Surs W,et al.Combination IL-2 and IL-4 reduces glucocortieoid receptor binding affinity and T cell response to glucecorticoids.Immunol,1993,151:3460-3466.

二级参考文献25

  • 1樊寻梅,武志远.国际儿科脓毒症定义会议介绍[J].中华儿科杂志,2005,43(8):618-620. 被引量:90
  • 2章赛吉(综述),张育才(审校).ACTH刺激试验在脓毒症和脓毒性休克中的应用进展[J].国际儿科学杂志,2007,34(2):107-110. 被引量:2
  • 3中华急诊医学会儿科学会急救学组.第4届全国小儿急救医学研讨会纪要[J].中华儿科杂志,1995,33:371-371.
  • 4Keh D, Sprung C. Use of eortieosteroid therapy in patients with sepsis and septic shock: An evidence-based review. Crit Care Med,2004, 32: S527-S523.
  • 5Armane D. Glucocorticoids in the treatment of severe sepsis and septic shock. Curt Opin Crit Care,2005,11 : 449-453.
  • 6Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet, 1991, 337: 582-583.
  • 7Armane D, Sebille V, Troche G, et al. A 3-level prognostic classification in sepsis shock base on cortisol level and cortisol response to eortieotrophin. JAMA. 2000. 283 : 1038-1045.
  • 8Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med,2005,6:2-8.
  • 9Pollack MM, Patel KM, Ruttimann UE. PRISM III: An updated pediatric risk of mortality score. Cfit Care Med, 1996,24:743- 752.
  • 10Pizarro CF, Troster E J, Damiani D, et al. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med, 2005, 33:855-859.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部